Needham Upgrades Phase Forward (PFWD) to Buy
More News related to PFWD
- Phase Forward Named Private Sector Company of the Year by Mass Technology Leadership Council
- Phase Forward Signs Multi-Year Agreement with Quotient Clinical for Use of InForm(TM) Electronic Data Capture Solution
- Phase Forward (PFWD) Announces $40M Share Buyback
- Phase Forward Announces Share Repurchase Program
- Phase Forward to Present at the 18th Annual Credit Suisse Healthcare Conference
More News related to Upgrades
- S&P Revises Outlook on Sirius XM (SIRI) from Stable to Positive
- DA Davidson Upgrade Lifts Shares of Ameron (AMN) by ~9%
- Sterne Agee Upgrades TrustCo Bank Corp NY (TRST) to Neutral
- optionsXpress (OXPS) Upgraded Mid-Day at BofA, Stock Adds 3% to Today's Gains
- D.A. Davidson Upgrades Columbia Sportswear (COLM) to Buy
Needham upgrades Phase Forward (Nasdaq: PFWD) from Hold to Buy with a $21 price target.
Phase Forward Incorporated provides integrated enterprise-level software products, services, and hosted solutions for use in clinical trial and drug safety monitoring activities in the United States, the United Kingdom, France, and the Asia Pacific.
Related Categories
UpgradesStocks Mentioned
+0.34Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
